Publication | Closed Access

Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr–Met, involves exclusion from the endocytic degradative pathway

Signal TransductionOncogenic ActivationSignaling PathwayCell RegulationReceptor Tyrosine KinaseMolecular BiologyCell BiologyMedicineProtein DegradationCell SignalingEndocytic Degradative PathwayProtein Phosphorylation